Form 8-K - Current report:
SEC Accession No. 0001628280-22-018940
Filing Date
2022-07-15
Accepted
2022-07-15 08:01:06
Documents
13
Period of Report
2022-07-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20220713.htm   iXBRL 8-K 37405
5 ardx-20220713_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-22-018940.txt   184514

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20220713.xsd EX-101.SCH 1899
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20220713_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20220713_pre.xml EX-101.PRE 13044
7 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20220713_htm.xml XML 11233
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 221084293
SIC: 2834 Pharmaceutical Preparations